These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32730781)

  • 21. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
    Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY
    Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doctoral Studies as part of an Innovative Training Network (ITN): Early Stage Researcher (ESR) experiences.
    Biswas R; Schiller A; Casolani C; Daoud E; Dode A; Genitsaridi E; Jacquemin L; Liyanage N; Lourenco M; Makani P; Parameshwarappa V; Riha C; L Santacruz J; Shabbir M; Simoes J; Trpchevska N; Schoisswohl S
    Open Res Eur; 2021; 1():34. PubMed ID: 37645158
    [No Abstract]   [Full Text] [Related]  

  • 25. A Game of Infection - Song of Respiratory Viruses and Interferons.
    Wang GQ; Gu Y; Wang C; Wang F; Hsu AC
    Front Cell Infect Microbiol; 2022; 12():937460. PubMed ID: 35846766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harnessing the power of RNA therapeutics in treating ischemic heart failure: the TRAIN-HEART story.
    Albert AM; Balamurali D; Beslika E; Fernandez ID; Genedy HH; Babaei Khorzoughi R; Lauta FC; Peppas P; Ragone I; Rizzari G; Sansonetti M; Silva J; Spanò G; Wrona KM
    Front Cardiovasc Med; 2023; 10():1228160. PubMed ID: 38274312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature.
    Hensel A; Bauer R; Heinrich M; Spiegler V; Kayser O; Hempel G; Kraft K
    Planta Med; 2020 Jul; 86(10):659-664. PubMed ID: 32434254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The innovative dimension of the research training programmes under H2020-MSCA-ITN: a methodological approach to track, measure and analyse innovative aspects and provide policy-feedback conclusions.
    Bitsios I; Martone F; Ricci R; Arfi A
    F1000Res; 2023; 12():1020. PubMed ID: 37771614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19, host response treatment, and the need for political leadership.
    Fedson DS
    J Public Health Policy; 2021 Mar; 42(1):6-14. PubMed ID: 33268844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections.
    Li W; Wang H; Zheng SJ
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAD+-consuming enzymes in immune defense against viral infection.
    Shang J; Smith MR; Anmangandla A; Lin H
    Biochem J; 2021 Dec; 478(23):4071-4092. PubMed ID: 34871367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differentiation, emergence and re-emergence of viral pathogens: past, present, future].
    Figas A
    Postepy Biochem; 2020 Dec; 66(4):373-378. PubMed ID: 33470076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.
    Rudiansyah M; Jasim SA; Mohammad Pour ZG; Athar SS; Jeda AS; Doewes RI; Jalil AT; Bokov DO; Mustafa YF; Noroozbeygi M; Karampoor S; Mirzaei R
    J Med Virol; 2022 Oct; 94(10):4611-4627. PubMed ID: 35689351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune responses in RNA viral infection.
    Xu Q; Tang Y; Huang G
    Front Med; 2021 Jun; 15(3):333-346. PubMed ID: 33263837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections.
    Gauthier T; Chen W
    Front Immunol; 2022; 13():780839. PubMed ID: 35154105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innovative training networks: overview of the Marie Skłodowska-Curie PhD training model.
    Doonan F; Taylor L; Branduardi P; Morrissey JP
    FEMS Microbiol Lett; 2018 Oct; 365(19):. PubMed ID: 30239741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease.
    Bornstein SR; Guan K; Brunßen C; Mueller G; Kamvissi-Lorenz V; Lechler R; Trembath R; Mayr M; Poston L; Sancho R; ; Ahmed S; Alfar E; Aljani B; Alves TC; Amiel S; Andoniadou CL; Bandral M; Belavgeni A; Berger I; Birkenfeld A; Bonifacio E; Chavakis T; Chawla P; Choudhary P; Cujba AM; Delgadillo Silva LF; Demcollari T; Drotar DM; Duin S; El-Agroudy NN; El-Armouche A; Eugster A; Gado M; Gavalas A; Gelinsky M; Guirgus M; Hansen S; Hanton E; Hasse M; Henneicke H; Heller C; Hempel H; Hogstrand C; Hopkins D; Jarc L; Jones PM; Kamel M; Kämmerer S; King AJF; Kurzbach A; Lambert C; Latunde-Dada Y; Lieberam I; Liers J; Li JW; Linkermann A; Locke S; Ludwig B; Manea T; Maremonti F; Marinicova Z; McGowan BM; Mickunas M; Mingrone G; Mohanraj K; Morawietz H; Ninov N; Peakman M; Persaud SJ; Pietzsch J; Cachorro E; Pullen TJ; Pyrina I; Rubino F; Santambrogio A; Schepp F; Schlinkert P; Scriba LD; Siow R; Solimena M; Spagnoli FM; Speier S; Stavridou A; Steenblock C; Strano A; Taylor P; Tiepner A; Tonnus W; Tree T; Watt F; Werdermann M; Wilson M; Yusuf N; Ziegler CG
    Horm Metab Res; 2021 Mar; 53(3):204-206. PubMed ID: 33652492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INSPIRE: A European training network to foster research and training in cardiovascular safety pharmacology.
    Guns PD; Guth BD; Braam S; Kosmidis G; Matsa E; Delaunois A; Gryshkova V; Bernasconi S; Knot HJ; Shemesh Y; Chen A; Markert M; Fernández MA; Lombardi D; Grandmont C; Cillero-Pastor B; Heeren RMA; Martinet W; Woolard J; Skinner M; Segers VFM; Franssen C; Van Craenenbroeck EM; Volders PGA; Pauwelyn T; Braeken D; Yanez P; Correll K; Yang X; Prior H; Kismihók G; De Meyer GRY; Valentin JP
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106889. PubMed ID: 32565326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ITN-VIROINF: Understanding (Harmful) Virus-Host Interactions by Linking Virology and Bioinformatics.
    Goettsch W; Beerenwinkel N; Deng L; Dölken L; Dutilh BE; Erhard F; Kaderali L; von Kleist M; Marquet R; Matthijnssens J; McCallin S; McMahon D; Rattei T; Van Rij RP; Robertson DL; Schwemmle M; Stern-Ginossar N; Marz M
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humanizing science: seven actions for PhD students to become next generation, future-proof scientists.
    Valks I; Satrio D; Reitsma A; Wolthers K; Dierickx K; Benschop K; Pajkrt D;
    Open Res Eur; 2022; 2():119. PubMed ID: 37900618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.